Valproate-induced thrombocytopenia: A prospective monotherapy study

Epilepsia

Volumn 49, Issue 3, 2008, Pages 438-445

  Nasreddine, Wassim ^a   Beydoun, Ahmad ^b  

^a Beirut Governmental University Hospital   (Lebanon)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Antiepileptic drugs; Gender effect; Plasma level; Platelet; Thrombocytopenia; Valproate

Indexed keywords

CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; VALPROATE SEMISODIUM;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOCAL EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; PARALLEL DESIGN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTICONVULSANTS; CHILD; DOUBLE-BLIND METHOD; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; PROBABILITY; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SEX FACTORS; THROMBOCYTOPENIA; TREATMENT OUTCOME; VALPROIC ACID;

EID: 39749201007     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2007.01429.x     Document Type: Article

References (34)

1. Allarakhia IN, Garofalo E, Komarynski MA, Robertson PL 1996) Valproic acid and thrombocytopenia in children: a case-controlled retrospective study. Pediatr Neurol 14 : 303 307.
2. Anderson GD, Lin Y-X, Berge C, Ojemann GA 1997) Absence of bleeding complications in patients undergoing cortical surgery while receiving valproate treatment. J Neurosurg 87 : 252 256.
3. Barr RD, Copeland SA, Stockwell ML, Morris N, Kelton JC 1982) Valproic acid and immune thrombocytopenia. Arch Dis Child 57 : 681 684.
4. Beydoun A, Sackellares JC, Shu V 1997) Safety and efficacy of divalproate sodium monotherapy in partial epilepsy: a double-blind, concentration-response design clinical trial. Neurology 48 : 182 188.
5. Conley EL, Coley KC, Pollock BG, Dapos SV, Maxwell R, Branch RA 2001) Prevalence and risk of thrombocytopenia with valproic acid: experience at a psychiatric teaching hospital. Pharmacotherapy 21 : 1325 1330.
6. Coulter DL, Wu H, Allen RJ 1980) Valproic acid therapy in childhood epilepsy. JAMA 244 : 785 788.
7. Delgado MR, Riela AR, Mills J, Browne R, Roach ES 1994) Thrombocytopenia secondary to high valproate levels in children with epilepsy. J Clin Neurol 9 : 311 314.
8. Ganick DJ, Sunder T, Finley JL 1990) Severe hematologic toxicity of valproic acid. A report of four patients. Am J Pediatr Hematol Oncol 12 : 80 85.
9. Gidal B, Spencer N, Maly M, Pitterle M, Williams E, Collins M, Jones J 1994) Valproate-mediated disturbances of hemostasis: relationship to dose and plasma concentration. Neurology 44 : 1418 1422.
10. Hauser E, Seidl R, Freilinger M, Male C, Herkner K 1996) Hematologic manifestations and impaired liver synthesis function during valproate monotherapy. Brain Dev 18 : 105 109.
11. Hoffman LM 1982) Sodium valproate and thrombocytopenia. Can Med Assoc J 126 : 358 359.
12. Kishi T, Fujita N, Kawaguchi H, Ishimae M, Watanabe K, Tanaka T 1994) Bone marrow suppression induced by high dose valproic acid. Arch Dis Child 71 : 153 155.
13. Levy RH 1984) Variability in level-dose ratio of valproate: monotherapy versus polytherapy. Epilepsia 25 : S10 S13.
14. Loiseau P, Brachet A, Henry P 1975) Concentration of dipropylacetate in plasma. Epilepsia 16 : 609 615.
15. Loiseau P 1981) Sodium valproate, platelet dysfunction, and bleeding. Epilepsia 22 : 141 146.
16. May RB, Sunder TR 1993) Hematological manifestations of long-term valproate therapy. Epilepsia 34 : 1098 1101.
17. Morris N, Barr RD, Pai KR, Kelton JG 1981) Valproic acid and thrombocytopenia. Can Med Assoc J 125 : 63 64.
18. Neophytides AN, Nutt JG, Lodish JR 1979) Thrombocytopenia associated with sodium valproate treatment. Ann Neurol 5 : 389 390.
19. Oluboka OJ, Haslam D, Gardner DM 2000) Pancytopenia and valproic acid: a dose-related association. J Am Geriatr Soc 48 : 349 350.
20. Raworth RE, Birchall G 1978) Sodium valproate and platelet count. Lancet 1 : 670 671.
21. Richardson SG, Fletcher DJ, Jeavons PM, Stuart J 1976) Sodium valproate and platelet function. Br Med J 1 : 221 222.
22. Robinson D, Langer A, Casso D, Fenn H, Yesavage J 1995) Pancytopenia and valproic acid-a possible association. J Am Geriatr Soc 43 : 198.
23. Sandler RM, Emberson C, Roberts GE, Voak D, Darnborough J, Heeley AF 1978) IgM platelet autoantibody due to sodium valproate. Br Med J 2 : 1683 1844.
24. Schobben F, Van Der Kleijn E 1974) Determination of sodium di-n-propylacetate in plasma by gas-liquid chromatography. Pharmacol Week 109 : 30 33.
25. Tohen M, Castillo J, Baldessarini RJ, Zarate C, Jr., Kando JC 1995) Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2,228 patients at risk. Am J Psychiatry 152 : 413 418.
26. Trannel TJ, Ahmed I, Doebert D 2001) Occurrence of thrombocytopenia in psychiatric patients taking valproate. Am J Psychiatry 158 : 128 130.
27. Turnbull DM, Rawlins MD, Weightman D, Chadwick DW 1983) Plasma concentrations of sodium valproate: their clinical value. Ann Neurol 14 : 38 42.
28. Vajda F, Morris P, Drummer O, Bladin P 1976) Clinical and pharmacological aspects of sodium valproate. In Legg NJ (Ed). Treatment of epilepsy. MCS Consultants, Tunbridge Wells, Kent, United Kingdom, pp. 91 100.
29. Verrotti A, Greco R, Matera V, Altobelli E, Morgese G, Chiarelli F 1999) Platelet count and function in children receiving sodium valproate. Pediatr Neurol 21 : 611 614.
30. Von Voss H, Petrich C, Karch D, Schultz H-U, Gobel U 1976) Sodium valproate and platelet function. BMJ 2 : 179 180.
31. Warkentin TE, Sheppard JA, Sigouin CS, Kohlmann T, Eichler P, Greinacher A 2006) Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia. Blood 108 : 2937 2941.
32. Winfield DA, Benton P, Espri MLE 1976) Sodium valproate and thrombocytopenia. BMJ 2 : 981.
33. Wulff K, Flachs H, Wurtz-Jorgensen A, Gram L 1977) Clinical pharmacological aspects of valproate sodium. Epilepsia 18 : 149 157.
34. Wyngaarden JB, Smith LH, Jr., Bennett JC 1992) Cecil textbook of medicine. 19th ed. WB Saunders, Philadelphia.